arrow
A

Adam Penn-Nicholson

Foundation for Innovative New Diagnostics
H指数:35
被引数:5,750

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Symptom-agnostic endpoints in tuberculosis vaccine efficacy trials

症状不依赖性终点在结核病疫苗效价试验中的应用

2026-10-010
OAAI
A cartridge-based assay for improved detection of multidrug-resistant Mycobacterium tuberculosis directly from sputum

基于卡盒的检测方法用于直接从痰液中提高多重耐药结核分枝杆菌的检测

2026-03-010
PRE
Risk Factors for Immunological Sensitization to Mycobacterium tuberculosis and Progression to Incident TB Disease Among HIV-uninfected Adults in a High Burden Setting

HIV阴性成人对结核分枝杆菌的免疫致敏及进展为新发结核病的危险因素研究

2026-02-180
OAAI
Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development

保障结核病疗法的未来发展:药物与耐药性检测并行开发的框架

2025-10-230
PRE
Sputum and Tongue Swab Molecular Testing for the In-Home Diagnosis of Tuberculosis in Unselected Household Contacts: A Cost and Cost-Effectiveness Analysis

痰液和舌拭子分子检测在非选择性家庭接触者居家结核病诊断中的应用:一项成本与成本效益分析

2025-08-011
PRE
Oral Swab Testing With Xpert MTB/RIF Ultra for the Diagnosis of Tuberculosis in Children Aged <5 Years in Uganda: An Exploratory Interim Analysis of Diagnostic Accuracy in the NOD-pedFEND Cohort

使用Xpert MTB/RIF Ultra进行口腔拭子检测以诊断5岁以下儿童结核病:NOD-pedFEND队列中诊断准确性的探索性中期分析

2025-04-080
OA
Performance of 2 Finger-Stick Blood Tests to Triage Adults With Symptoms of Pulmonary Tuberculosis: A Prospective Multisite Diagnostic Accuracy Study
2025-04-010
PRE
Diagnostic Accuracy of LiquidArray MTB-XDR VER 1.0 for the Detection of Mycobacterium tuberculosis Complex, Fluoroquinolone, Amikacin, Ethambutol, and Linezolid Susceptibility

LiquidArray mtb-xdr VER 1.0用于检测结核分枝杆菌复合体,氟喹诺酮,阿米卡星,乙胺丁醇和利奈唑胺敏感性的诊断准确性

2024-12-120
PRE
Co-regulation of innate and adaptive immune responses induced by ID93+GLA-SE vaccination in humans

ID93 GLA-SE疫苗在人类中诱导的先天和适应性免疫应答的共调节

2024-09-240
OAAI
Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial)
2024-08-151
OAAI
Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens: A Clinical Laboratory-Based Diagnostic Accuracy and Feasibility Study in South Africa
2024-07-312
OAAI
In-home TB Testing Using GeneXpert Edge is Acceptable, Feasible, and Improves the Proportion of Symptomatic Household Contacts Tested for TB: A Proof-of-Concept Study

使用GeneXpert Edge进行家庭结核病检测是可接受的,可行的,并提高了接受结核病检测的有症状家庭接触者的比例: 一项概念验证研究

2024-05-132
OAAI
Transcriptomic Signatures of Progression to Tuberculosis Disease Among Close Contacts in Brazil

巴西密切接触者中结核病进展的转录组学特征

2024-05-060
OAAI
Diagnostic accuracy of tongue swab testing on two automated tuberculosis diagnostic platforms, Cepheid Xpert MTB/RIF Ultra and Molbio Truenat MTB Ultima

在两个自动结核病诊断平台Cepheid Xpert MTB/RIF Ultra和Molbio Truenat MTB Ultima上进行舌拭子测试的诊断准确性

2024-04-107
OA
Study protocol: a pragmatic, cluster-randomized controlled trial to evaluate the effect of implementation of the Truenat platform/MTB assays at primary health care clinics in Mozambique and Tanzania (TB-CAPT CORE)
2024-01-190
OAAI